What is the most recent earnings date for ZVRA stock?
ZEVRA THERAPEUTICS INC (ZVRA) last reported earnings on 3/9/2026.
ZEVRA THERAPEUTICS INC (ZVRA) Earnings History & Surprises
NASDAQ:ZVRA • US4884452065
Current stock price
8.78 USD
-0.38 (-4.15%)
At close:
8.58 USD
-0.2 (-2.28%)
After Hours:
ZVRA Earnings overview
Past quarterly earnings results for ZEVRA THERAPEUTICS INC (ZVRA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.09
- Revenue Estimate
- 32.6M
Last Reported
Most Recent- Release Date
- Mar 9, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.21
- EPS Surprise
- 311.76%
- Revenue Surprise
- 19.27%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.21 | 0.05 | 311.76% | 130.43% | 34.125M | 28.612M | 19.27% | 183.36% |
| Q3 2025 | -0.01 | -0.04 | 71.99% | 98.55% | 26.063M | 27.161M | -4.04% | 605.36% |
| Q2 2025 | 1.21 | 1.53 | -20.80% | 352.08% | 25.881M | 22.986M | 12.59% | 481.73% |
| Q1 2025 | -0.06 | -0.19 | 68.49% | 85.00% | 20.401M | 17.297M | 17.95% | 495.65% |
| Q4 2024 | -0.69 | -0.41 | -67.34% | -72.50% | 12.043M | 9.104M | 32.28% | -8.88% |
| Q3 2024 | -0.69 | -0.43 | -60.59% | -72.50% | 3.695M | 4.966M | -25.59% | 27.63% |
| Q2 2024 | -0.48 | -0.44 | -8.43% | -220.00% | 4.449M | 4.443M | 0.14% | -47.47% |
| Q1 2024 | -0.40 | -0.49 | 17.96% | -17.65% | 3.425M | 3.839M | -10.78% | 18.96% |
| Q4 2023 | -0.40 | -0.27 | -46.15% | -53.85% | 13.217M | 11.973M | 10.39% | 469.70% |
| Q3 2023 | -0.40 | -0.30 | -31.82% | -110.53% | 2.895M | 3.447M | -16.01% | 0.87% |
| Q2 2023 | -0.15 | -0.35 | 57.17% | 21.05% | 8.47M | 3.094M | 173.76% | 551.54% |
| Q1 2023 | -0.34 | -0.24 | -43.37% | -580.00% | 2.879M | 2.708M | 6.31% | -27.48% |
| Q4 2022 | -0.26 | -0.18 | -47.06% | -225.00% | 2.32M | 3.264M | -28.92% | -10.08% |
| Q3 2022 | -0.19 | -0.13 | -43.29% | -280.00% | 2.87M | 3.264M | -12.07% | 45.69% |
| Q2 2022 | -0.19 | -0.12 | -55.23% | -190.48% | 1.3M | 1.836M | -29.19% | -89.16% |
| Q1 2022 | -0.05 | -0.06 | 10.87% | 90.74% | 3.97M | 3.126M | 27.00% | -67.24% |
| Q4 2021 | -0.08 | -0.08 | -4.58% | 92.52% | 2.58M | 2.28M | 13.16% | 8.86% |
| Q3 2021 | -0.05 | -0.08 | 34.64% | 92.19% | 1.97M | 2.228M | -11.58% | 2.07% |
| Q2 2021 | 0.21 | 0.23 | -8.50% | 31.25% | 11.99M | 12.342M | -2.85% | 73.52% |
| Q1 2021 | -0.54 | -0.17 | -211.42% | 69.32% | 12.12M | 2.142M | 465.83% | 479.90% |
| Q4 2020 | -1.07 | -0.65 | -63.91% | - | 2.37M | 2.04M | 16.18% | - |
| Q3 2020 | -0.64 | -0.82 | 21.57% | - | 1.93M | 1.938M | -0.41% | - |
| Q2 2020 | 0.16 | 0.00 | - | - | 6.91M | 6.885M | 0.36% | - |
| Q1 2020 | -1.76 | 0.16 | -1,178.43% | - | 2.09M | 5.916M | -64.67% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
107.86%
Max EPS beat (4)
311.77%
Min EPS beat (4)
-20.80%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
11.44%
Max Revenue beat (4)
19.27%
Min Revenue beat (4)
-4.04%
Analysis
In the last 4 quarters, ZVRA has beaten EPS estimates in 3 out of 4 releases
ZVRA has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ZVRA has beaten the EPS estimates by 107.9% on average.
In the last 4 quarters, ZVRA has beaten the revenue estimates by 11.4% on average.
Related analysis
ZEVRA THERAPEUTICS INC / ZVRA Earnings FAQ
Did ZVRA stock beat earnings estimates in the most recent quarter?
ZEVRA THERAPEUTICS INC (ZVRA) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ZVRA stock beat earnings estimates?
In the last 4 quarters, ZEVRA THERAPEUTICS INC (ZVRA) has beaten EPS estimates in 3 out of 4 releases.